Source: The Hindu Business Line

Nesher: Zydus arm gets USFDA nod for antibiotic to treat skin infection

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Nystatin Topical Powder USP, 100,000 units per gram.The drug will be produced at...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100